{
    "organizations": [],
    "uuid": "a2e6575278d4891ba604dac65db6affea8fa082e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-lexicon-announces-regulatory-submi/brief-lexicon-announces-regulatory-submissions-for-sotagliflozin-to-treat-adults-with-type-1-diabetes-idUSFWN1R80MF",
    "ord_in_thread": 0,
    "title": "BRIEF-Lexicon Announces Regulatory Submissions For Sotagliflozin To Treat Adults With Type 1 Diabetes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26, 2018 / 11:51 AM / in 6 minutes BRIEF-Lexicon Announces Regulatory Submissions For Sotagliflozin To Treat Adults With Type 1 Diabetes Reuters Staff March 26 (Reuters) - Lexicon Pharmaceuticals Inc: * LEXICON PHARMACEUTICALS ANNOUNCES REGULATORY SUBMISSIONS FOR SOTAGLIFLOZIN TO TREAT ADULTS WITH TYPE 1 DIABETES * LEXICON PHARMA - SANOFI SUBMITTED NDA TO FDA FOR SOTAGLIFLOZIN COMBINED WITH INSULIN THERAPY TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 1 DIABETES Source text for Eikon: Further company coverage:",
    "published": "2018-03-26T14:49:00.000+03:00",
    "crawled": "2018-03-26T15:03:40.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "announces",
        "regulatory",
        "submission",
        "sotagliflozin",
        "treat",
        "adult",
        "type",
        "diabetes",
        "reuters",
        "staff",
        "march",
        "reuters",
        "lexicon",
        "pharmaceutical",
        "inc",
        "lexicon",
        "pharmaceutical",
        "announces",
        "regulatory",
        "submission",
        "sotagliflozin",
        "treat",
        "adult",
        "type",
        "diabetes",
        "lexicon",
        "pharma",
        "sanofi",
        "submitted",
        "nda",
        "fda",
        "sotagliflozin",
        "combined",
        "insulin",
        "therapy",
        "improve",
        "glycemic",
        "control",
        "adult",
        "type",
        "diabetes",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}